AAPL   322.04 (+1.29%)
MSFT   182.73 (-0.29%)
FB   229.56 (+1.99%)
GOOGL   1,433.73 (+0.01%)
AMZN   2,470.41 (+1.15%)
NVDA   352.04 (-0.84%)
CGC   16.40 (-5.58%)
GE   6.69 (+1.67%)
TSLA   882.78 (+5.72%)
AMD   53.73 (-0.13%)
T   31.13 (+0.87%)
ACB   14.19 (+0.78%)
F   5.86 (+2.63%)
GILD   75.25 (-3.31%)
DIS   118.94 (+1.40%)
NFLX   423.49 (+0.90%)
BAC   24.68 (+2.28%)
BA   150.97 (+3.48%)
AAPL   322.04 (+1.29%)
MSFT   182.73 (-0.29%)
FB   229.56 (+1.99%)
GOOGL   1,433.73 (+0.01%)
AMZN   2,470.41 (+1.15%)
NVDA   352.04 (-0.84%)
CGC   16.40 (-5.58%)
GE   6.69 (+1.67%)
TSLA   882.78 (+5.72%)
AMD   53.73 (-0.13%)
T   31.13 (+0.87%)
ACB   14.19 (+0.78%)
F   5.86 (+2.63%)
GILD   75.25 (-3.31%)
DIS   118.94 (+1.40%)
NFLX   423.49 (+0.90%)
BAC   24.68 (+2.28%)
BA   150.97 (+3.48%)
AAPL   322.04 (+1.29%)
MSFT   182.73 (-0.29%)
FB   229.56 (+1.99%)
GOOGL   1,433.73 (+0.01%)
AMZN   2,470.41 (+1.15%)
NVDA   352.04 (-0.84%)
CGC   16.40 (-5.58%)
GE   6.69 (+1.67%)
TSLA   882.78 (+5.72%)
AMD   53.73 (-0.13%)
T   31.13 (+0.87%)
ACB   14.19 (+0.78%)
F   5.86 (+2.63%)
GILD   75.25 (-3.31%)
DIS   118.94 (+1.40%)
NFLX   423.49 (+0.90%)
BAC   24.68 (+2.28%)
BA   150.97 (+3.48%)
AAPL   322.04 (+1.29%)
MSFT   182.73 (-0.29%)
FB   229.56 (+1.99%)
GOOGL   1,433.73 (+0.01%)
AMZN   2,470.41 (+1.15%)
NVDA   352.04 (-0.84%)
CGC   16.40 (-5.58%)
GE   6.69 (+1.67%)
TSLA   882.78 (+5.72%)
AMD   53.73 (-0.13%)
T   31.13 (+0.87%)
ACB   14.19 (+0.78%)
F   5.86 (+2.63%)
GILD   75.25 (-3.31%)
DIS   118.94 (+1.40%)
NFLX   423.49 (+0.90%)
BAC   24.68 (+2.28%)
BA   150.97 (+3.48%)
Log in

OTCMKTS:PCYNProcyon Stock Price, Forecast & News

$0.32
+0.09 (+39.13 %)
(As of 06/1/2020 08:32 AM ET)
Add
Compare
Today's Range
$0.32
Now: $0.32
$0.32
50-Day Range
$0.24
MA: $0.25
$0.26
52-Week Range
$0.19
Now: $0.32
$0.65
Volume500 shs
Average Volume9,267 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems primarily in the United States. The company offers advanced skin and wound care products, including the hydrogel wound dressing products, post op surgical kits, saline wound washes, care lotions, and barrier lotions to promote healing in wound and problematic skin conditions under the AMERIGEL brand name. It also provides Bioactive Collagen products under the HELIX3 brand name. In addition, the company offers wound care products, such as calcium alginate, foam, gauze, and hyrdocolloid dressing products; wound care kits, which include calcium alginate, collagen matrix, collagen powder, foam, and hydrogel wound care kits under the AMERX brand name; and compression garment line products under the EXTREMIT-EASE name. It sells its products through distributors to institutional customers, such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, physicians, and other health care practitioners; and retail customers through direct sales, and Internet sales, as well as through independent and retail chain drug stores. Procyon Corporation was incorporated in 1987 and is based in Clearwater, Florida.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.40 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PCYN
CUSIP742806300
Phone727-447-2998

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees16
Next Earnings DateN/A
OptionableNot Optionable

Receive PCYN News and Ratings via Email

Sign-up to receive the latest news and ratings for PCYN and its competitors with MarketBeat's FREE daily newsletter.

Procyon (OTCMKTS:PCYN) Frequently Asked Questions

How has Procyon's stock been impacted by COVID-19 (Coronavirus)?

Procyon's stock was trading at $0.25 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PCYN shares have increased by 28.0% and is now trading at $0.32. View which stocks have been most impacted by Coronavirus.

Has Procyon been receiving favorable news coverage?

News articles about PCYN stock have trended somewhat positive on Monday, InfoTrie Sentiment reports. The research group identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Procyon earned a media sentiment score of 1.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news aboutProcyon.

Who are some of Procyon's key competitors?

What other stocks do shareholders of Procyon own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Procyon investors own include California Republic Bancorp (CRPB), Aphria (APHA) and Aerie Pharmaceuticals (AERI).

Who are Procyon's key executives?

Procyon's management team includes the following people:
  • Mr. Justice W. Anderson, CEO, Pres & Director (Age 42)
  • Mr. James B. Anderson, CFO & Director (Age 49)
  • Mr. George Otis Borak, VP of Sales - Amerx Health Care Corp. (Age 58)

What is Procyon's stock symbol?

Procyon trades on the OTCMKTS under the ticker symbol "PCYN."

How do I buy shares of Procyon?

Shares of PCYN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Procyon's stock price today?

One share of PCYN stock can currently be purchased for approximately $0.32.

What is Procyon's official website?

The official website for Procyon is procyoncorp.com.

How can I contact Procyon?

The company can be reached via phone at 727-447-2998.

This page was last updated on 6/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.